Key facts
- This page summarizes Eli Samaha's Form 3 filing for Theravance Biopharma, Inc. (TBPH).
- 0 reported transactions and 0 derivative rows are listed below.
- Accepted by SEC: 21 Oct 2022, 19:35.
Eli Samaha - 20 Sep 2022 Form 3 Insider Report for Theravance Biopharma, Inc. (TBPH)
- Reporting relationship
- 10%+ Owner
- Issuer ticker
- TBPH
- Reported as of
- 20 Sep 2022
- Net transaction value
- $0
- SEC form
- 3
- Accepted by SEC
- 21 Oct 2022, 19:35:50 UTC
- Prior SEC filing
- 28 Jun 2022
- Next SEC filing
- 30 Dec 2022
- Source filing
- View source filing
- Reporting owner signature
- Eli Samaha
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Eli Samaha filed Form 3 for Theravance Biopharma, Inc. (TBPH) on 21 Oct 2022.
Change
- Previous filing in this sequence was filed on 28 Jun 2022.
- Current net transaction value: $0.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Official SEC source
View source filing
Ownership activity is grounded in SEC Form 3 disclosures.
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
TBPH
holding
COM
No transaction description listed
- Transaction value
- Shares
- Change %
- Price
- Shares after
- 7,012,226
- Date
- 20 Sep 2022
- Ownership
- See footnote
- Footnotes
- F1
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
These shares are held by funds managed by Madison Avenue Partners, LP. The Reporting Person is the managing partner of Madison Avenue Partners, LP. The Reporting Person disclaims beneficial ownership of these securities, except to the extent of the pecuniary interest of the Reporting Person in the funds. The filing of this statement shall not be deemed an admission that, for purposes of Section 16 of the Securities Exchange Act of 1934, as amended, or otherwise, the Reporting Person is the beneficial ownership of such securities.